Market Place
Sourcing Support
LIR Life Partners with Neuland Labs on Transdermal GLP-1/GIP
08 Jan 2026 //
PRESS RELASE
Neuland, Lupin, Divi`s Lead CDMO Surge Amid U.S. Generics Woes
25 Nov 2025 //
BUSINESS STD
Q2 FY 26 – Financial Results Newspaper Publication
08 Nov 2025 //
PRESS RELEASE
Mr. Sucheth, VC and Chief Executive Officer of Neuland Lab
04 Nov 2025 //
PRESS RELEASE
Neuland Laboratories Q2FY26
24 Oct 2025 //
PRESS RELEASE
Neuland Manufacturing Unit-I Has Been Awarded the Sword of Honour
22 Oct 2025 //
PRESS RELEASE
Signed SE Intimation Trading Window Closure Q2FY26
25 Sep 2025 //
PRESS RELEASE
Neuland’ Manufacturing Unit I secured a Five-Star Safety Rating
29 Aug 2025 //
PRESS RELEASE
Q1 FY 26 – Financial Results Newspaper Publication
01 Aug 2025 //
PRESS RELEASE
Neuland Labs GHG Emission Reduction Targets Approved by SBTi
31 Jul 2025 //
PRESS RELEASE
Outcome of Board Meeting – 31/07/2025
31 Jul 2025 //
PRESS RELEASE
Building a More Sustainable Supply Chain in Pharma
23 Jun 2025 //
PRESS RELEASE
Neuland Labs Q4 FY25 PAT: Rs. 27.80 Cr
18 May 2025 //
INDPHARMAPOST
Neuland Reaffirms Commitment to United Nations Global Principles
08 Apr 2025 //
PRESS RELEASE
Neuland Labs has been awarded a ‘Silver Medal’
26 Mar 2025 //
PRESS RELEASE
Neuland Has Submitted 1st Peptide DMF for Difelikefalin Acetate
26 Mar 2025 //
PRESS RELEASE
Neuland appoints Parag Deshmukh as SVP Head of Manufacturing
24 Mar 2025 //
INDPHARMAPOST
Q3 FY 25 – Financial Results Newspaper Publication
11 Feb 2025 //
PRESS RELEASE
Neuland Labs board approves Capex of Rs. 342 Cr
23 Jan 2025 //
INDPHARMAPOST
Neuland Labs Announces a $30M Investment
21 Jan 2025 //
PRESS RELEASE
Neuland Labs achieved an outstanding ESG Score of 70/100
13 Jan 2025 //
PRESS RELEASE
Neuland Labs Proudly Announces New Vision and Values Statements
07 Jan 2025 //
PRESS RELEASE
Neuland Labs has been recognised as the ‘Top Value Creator’
29 Nov 2024 //
PRESS RELEASE
Essential Role of Intellectual Property in Pharmaceutical API Company
14 Nov 2024 //
PRESS RELEASE
Q2 FY 25 Financial Results Newspaper Publication
07 Nov 2024 //
PRESS RELEASE
Outcome of Board Meeting – 06/11/2024
06 Nov 2024 //
PRESS RELEASE
Achieving Drug Development Success: Neuland’s Three-Pillar Strategy
03 Oct 2024 //
PRESS RELEASE
Securing Sustainability in Pharma Supply Chain – Sucheth Davuluri
01 Oct 2024 //
PRESS RELEASE
Defining New Rules – The Evolution of the CDMO Industry – Saharsh
02 Sep 2024 //
PRESS RELEASE
From the Neuland Reading Room: Peptide Trends in 2024
02 Sep 2024 //
PRESS RELEASE
Zero Liquid Discharge: Pharma Industry Commitment To Sustainability
02 Aug 2024 //
PRESS RELEASE
Zero Liquid Discharge: A Pharma Industry Commitment to Environment
02 Aug 2024 //
PRESS RELEASE
Neuland Labs Q1FY25
17 Jul 2024 //
PRESS RELEASE
The Pharma Supply Chain: Reshaping Itself for The New Normal
03 Jul 2024 //
PRESS RELEASE
Pharma Supply Chain: Reshaping Itself for The New Normal
03 Jul 2024 //
PRESS RELEASE
Neuland unveils its dynamic new brand identity reinforcing
10 Jun 2024 //
PRESS RELEASE
Neuland unveils refreshed brand identity
07 Jun 2024 //
PRESS RELEASE
Neuland Laboratories Q4 FY24 Earnings Conference Call May 14, 2024
14 May 2024 //
PRESS RELEASE
A Check-in on 2024 Trends in the CDMO Industry
02 May 2024 //
PRESS RELEASE
How to Ensure Effective Technology Transfer to CDMOs
28 Mar 2024 //
PRESS RELEASE
Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility
25 Mar 2024 //
MONEYCONTROL
Neuland Labs Unit I Plant Passes USFDA Audit With Zero 483 Observations Again
24 Mar 2024 //
PRESS RELEASE
Why Agility Matters When Choosing an API Contract Manufacturing Partner
04 Mar 2024 //
PRESS RELEASE
Neuland Laboratories Q3 & 9M FY24 Earnings Conference Call” February 09, 2024
13 Feb 2024 //
LIVE MINT
Neuland Q3FY24 income
09 Feb 2024 //
PRESS RELEASE
Board Meeting Outcome Unaudited Q3 FY2023-24 Financial Results
08 Feb 2024 //
PRESS RELEASE
API Particle Size Part 2: New & Emerging Technologies Impacting Particle Size
01 Feb 2024 //
PRESS RELEASE
Unaudited Financial Results (Consolidated and Standalone) for Q2 FY 2024
07 Nov 2023 //
PRESS RELEASE
Unaudited Financial Results (Consolidated and Standalone) for Q1 FY 2024
03 Aug 2023 //
PRESS RELEASE
Neuland Lab Consolidated June 2023 Net Sales at Rs 362.99 crore, up 64.12% Y-o-Y
03 Aug 2023 //
MONEY CONTROL
Neuland Labs Share Jumps 44% in 3 Days on Strong Q4 Results
15 May 2023 //
EQUITYPANDIT
Neuland Laboratories appoints Abhijit Majumdar as CFO
24 Nov 2022 //
INDIANPHARMAPOST
End-to-End Focus on Quality in API Manufacturing
31 Oct 2022 //
PRESS RELEASE
Ensuring Rock-Solid IT Infrastructure in Contract Manufacturing
30 Sep 2022 //
PRESS RELEASE
Neuland Annual Report FY 2021-22
27 Sep 2022 //
PRESS RELEASE
SE Intimation – Resignation of Chief Financial Officer
13 Sep 2022 //
PRESS RELEASE
3 Key Elements of a Successful Hydrogenation Scale-Up
30 Aug 2022 //
PRESS RELEASE
Pharma Industry Zeroes in on Drug Manufacturing Sustainability
31 Jul 2022 //
PRESS RELEASE
A Novel Method of Manufacturing Alcaftadine
29 Jun 2022 //
PRESS RELEASE
